Drug Profile
QLT 091568
Alternative Names: OT-730Latest Information Update: 30 Nov 2016
Price :
$50
*
At a glance
- Originator Othera Pharmaceuticals
- Class Antiglaucomas; Antihypertensives; Small molecules
- Mechanism of Action Beta-adrenergic receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Glaucoma; Ocular hypertension